Scientists at Stanford University have unveiled a detailed laboratory protocol for a high-throughput drug screening platform designed to find compounds capable of treating cardiac fibrosis, the stiffening of heart tissue that accompanies heart attacks, genetic cardiomyopathies, diabetes and aging. Writing in Nature Protocols, the team led by Hao Zhang and Joseph C. Wu describes a […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.